Non-Parenchymal Cell Biology

Ning Qin,Tao Chen,Lin Zhu,Ding Liu,Li Song,Xiaoping Zhu,Aichao Shi,Xiaoping Li,Alexander Hodge,Dinushka Lourensz,Jorge Tchongue,George Yeoh,Rebecca Lim,William Sievert,Victoria L. Gadd,Richard Skoien,Kevin J. Fagan,Katharine M. Irvine,Elizabeth E. Powell,Andrew D. Clouston
DOI: https://doi.org/10.1002/hep.26847
IF: 17.298
2013-01-01
Hepatology
Abstract:murine hepatitis virus strain 3 (MHV-3) induced fulminant viral hepatitis (MHV-3-FVH) mice model was adopted in the study.The mouse KCTD9 (mKCTD9) expression plasmid and an shRNA plasmid specifically targeting this molecule were constructed and introduced into infected mice by hydrodynamic delivery.The expression of KCTD9 as well as function of hepatic NK cells was detected, respectively.Results: The results showed abundant expression of KCTD9 in hepatic NK cells from mice with MHV-3 infection.The shRNA significantly inhibited KCTD9 expression in hepatic NK cells with decreased CD69 expression, cytotoxicity and ameliorated MHV-3-FVH in these mice demonstrating as an increased survival, improved liver functions and histopathology manifestation.In contrast, delivery of the KCTD9 expression plasmid to MHV-3-infected mice led to a profound progression of liver disease.Conclusion: Our study further elaborated the novel KCTD9 gene contributes to liver injury through NK cell activation in virus-induced liver failure, while interference targeting KCTD9 gene could ameliorated the disease, which provide a potential therapeutic target for virus induced liver failure.
What problem does this paper attempt to address?